AAAAAA
Results:
1-8
|
Results: 8
Authors:
McCann, GP
Muir, DF
Hillis, WS
Citation: Gp. Mccann et al., Exercise testing, symptoms, and clinical outcome in aortic stenosis, HEART, 83(1), 2000, pp. 105-105
Authors:
Mccann, GP
Muir, DF
Hillis, WS
Citation: Gp. Mccann et al., Athletic left ventricular hypertrophy: long-term studies are required, EUR HEART J, 21(5), 2000, pp. 351-353
Authors:
McCann, GP
Cahill, H
Knipe, S
Muir, DF
MacIntyre, PD
Hillis, WS
Citation: Gp. Mccann et al., Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism? (vol 98, pg 643, 2000), CLIN SCI, 99(3), 2000, pp. 253-253
Authors:
McCann, GP
Cahill, H
Knipe, S
Muir, DF
MacIntyre, PD
Hills, WS
Citation: Gp. Mccann et al., Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism?, CLIN SCI, 98(6), 2000, pp. 643-648
Authors:
Muir, DF
McCann, GP
Hillis, WS
Citation: Df. Muir et al., Triptans and coronary spasm - Reply, CLIN PHARM, 68(3), 2000, pp. 338-338
Authors:
Swan, L
Hood, S
Birnie, DH
Muir, DF
McCann, GP
Hillis, WS
Citation: L. Swan et al., The haemodynamic effect of the 5HT(1) agonist BMS-180048: a class effect of triptans?, BR J CL PH, 47(2), 1999, pp. 189-194
Authors:
Muir, DF
MacGregor, GD
McCann, GP
Hillis, WS
Citation: Df. Muir et al., The prevalence of left ventricular hypertrophy in elite professional footballers, INT J CARD, 71(2), 1999, pp. 129-134
Authors:
Muir, DF
McCann, GP
Swan, L
Clark, AL
Hillis, WS
Citation: Df. Muir et al., Hemodynamic and coronary effects of intravenous eletriptan, a 5HT(1B/1D)-receptor agonist, CLIN PHARM, 66(1), 1999, pp. 85-90
Risultati:
1-8
|